Feasibility of labetalol and nicardipine as a part of general anesthetics

CHEN Beilei,JIN Jue,XUE Qingsheng,YU Buwei
2013-01-01
Abstract:Objective To test the hypothesis that nicardipine and labetalol can attenuate cardiovascular responses to tracheal intubation, carbon dioxide pneumoperitoneum and operative stimulation by replacing parts of the volatile anesthetics and opioid analgesics during laparoscopic cholecystectomy under general anesthesia, and also to evaluate the time and quality of recovery. Methods A total of 68 patients Ameraican Society of Anesthesiologists grade Ⅰ or Ⅱ, 20—60 years old) scheduled for laparoscopic cholecystectomy were randomly assigned to four groups. Anesthesia induction was conducted with propofol 2 mg/kg, fentanyl 2 μg/kg and atracurium 0.6 mg/kg. Labetalol or nicardipine was administered 2 min before endotracheal intubation. Control group (n=16) was given normal saline (2 mL). Labetalol group (n=18) was given labetalol (2 mg). Nicardipine group (n=17) was given nicardipine (1 mg). Combined group (n=17) received labetalol (1 mg) and nicardipine (0.5 mg). The anesthesia was maintained with desflurane, fentanyl and atracurium, and bispectral index (BIS) was monitored during anesthesia. Labetalol and nicardipine were used to control the stress response in intraoperative period. Mean arterial pressure (MAP) and heart rate (HR) were maintained within ±20% vs. the baseline level. HR, MAP and BIS were recorded before and after pneumoperitoneum, every 5 min during operation and after operation. The concentration of end-expiration desflurane was also recorded. The mean data of every 5 min during the operative period represented for the intraoperative data. The duration of the operative precedure and fentanyl injection and the dose of medicines were recorded. Quality evaluation, including the time of eye open, extubation, obeying simple instruction, and recovery of orientation and BIS, was conducted every 1 or 2 min in the recovery period. Patient’s conditions, such as agitation, nausea and vomiting, and pain were recorded from the recovery to 6 hours after operation. Ondansetron (4 mg per time) was given to the patients who had nausea and vomiting. Fentanyl (0.05 mg per time) was given to the patients who had abdominal pain. The doses of these medicines were collected. Intraoperative awareness was assessed at 6 hours after recovery. Results HR in labetalol group was significantly lower than those in control group at 1 min and 2 min after intubation, during operation, and at the end of the operation (P<0.01). HR in combined group was significantly lower than those in control group at 1 min after intubation, during operation, and at the end of the operation (P<0.01, 0.05). HR in labetalol group and combined group were significantly lower than those in nicardipine group during operation and at the end of the operation (P<0.01, 0.05). MAP in the three medicine groups were significantly lower than those in the control group before intubation, at 1, 2 and 3 min after intubation, and after pneumoperitoneum (P<0.05, 0.01). BIS in the nicardipine group at 3 min after intubation and in the combined group at 2 and 3 min after intubation were significantly lower than that in the control group (P<0.05). BIS in the labetalol group during operation and in the nicardipine group and combined group during and after operation were significantly higher than those in the control group (P<0.05, 0.01). BIS in the nicardipine group and combined group were significantly higher than those in the labetalol group during and after operation (P<0.05, 0.01). Additional 30—120 mg propofol were given to 7 patients in the control group. The doses of the medicines used were as follows: 1—7 mg labetalol in labetalol group, 0.5—2 mg nicardipine in nicardipine group, 1—5 mg labetalol and 1—2 mg nicardipine in combined group. The concentration of end-expiration desflurane in the three medicine groups was significantly lower than that in the control group after pneumoperitoneum and during operation (P<0.01). The concentrations of end-expiration desflurane in nicardipine group during and after operation and in combined group after pneumoperitoneum and during operation were significantly lower than those in labetalol group (P<0.01). There were no awareness during operation. There was no significant difference in BIS in recovery time among different groups (P>0.05). The time of eye open, extubation and recovery of orientation in labetalol group were significantly shorter than those in the control group (P<0.05). The above mentioned time periods in nicardipine group and combined group were significantly shorter than those in control group and labetalol group (P<0.05). There were no significant differences in the incidence of agitation, nausea and vomiting and the dose of ondansetron among different groups (P>0.05). The incidence of pain and the dose of fentanyl in nicardipine group and combined group were significantly lower than those in control group (P<0.05). Conclusion The adjunctive use of labetalol and nicardipine as a part of anesthetics during laparoscopic cholecystectomy can attenuate the hemodynamic response to tracheal intubation, pneumoperitoneum, stress reaction of surgical stimuli and the use of desflurane. Nicardipine is more effective than labetalol. Labetalol and nicardipine do not increase the risk of awareness during surgery, and can shorten the recovery time and improve recovery quality. Nicardipine can decrease the incidence of pain and the requirement of opioids after surgery.
What problem does this paper attempt to address?